Ichiro Kishimoto

6.9k total citations · 1 hit paper
111 papers, 5.2k citations indexed

About

Ichiro Kishimoto is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Ichiro Kishimoto has authored 111 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Cardiology and Cardiovascular Medicine, 34 papers in Molecular Biology and 19 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Ichiro Kishimoto's work include Heart Failure Treatment and Management (33 papers), Regulation of Appetite and Obesity (18 papers) and Cardiac Fibrosis and Remodeling (18 papers). Ichiro Kishimoto is often cited by papers focused on Heart Failure Treatment and Management (33 papers), Regulation of Appetite and Obesity (18 papers) and Cardiac Fibrosis and Remodeling (18 papers). Ichiro Kishimoto collaborates with scholars based in Japan, United States and New Zealand. Ichiro Kishimoto's co-authors include David L. Garbers, Kazuwa Nakao, Takeshi Tokudome, Kenji Kangawa, Yoshihiro Ogawa, Yasato Komatsu, Takeshi Horio, Osamu Nakagawa, Koichiro Kuwahara and Sachie Suga and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Ichiro Kishimoto

110 papers receiving 5.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an "emergency" cardiac hormone against ventricular overload.

1995 536 citations Osamu Nakagawa, Yoshihiro Ogawa et al. Journal of Clinical Investigation profile →

Peers

Countries citing papers authored by Ichiro Kishimoto

Since Specialization

Citations

This map shows the geographic impact of Ichiro Kishimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ichiro Kishimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ichiro Kishimoto more than expected).

Fields of papers citing papers by Ichiro Kishimoto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ichiro Kishimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ichiro Kishimoto. The network helps show where Ichiro Kishimoto may publish in the future.

Co-authorship network of co-authors of Ichiro Kishimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Ichiro Kishimoto. A scholar is included among the top collaborators of Ichiro Kishimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ichiro Kishimoto. Ichiro Kishimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Subclinical Reactive Hypoglycemia with Low Glucose Effectiveness—Why We Cannot Stop Snacking despite Gaining Weight 2023 ·Metabolites ·Ichiro Kishimoto	3
2	Ghrelin and Blood Pressure Regulation 2016 ·Current Hypertension Reports ·Yuanjie Mao, Takeshi Tokudome, Ichiro Kishimoto	39
3	Characteristics and prognosis of patients with thyroglobulin-positive and radioactive iodine whole-body scan-negative differentiated thyroid carcinoma 2015 ·Japanese Journal of Clinical Oncology ·Shogo Shinohara, Masahiro Kikuchi, (unknown), Ichiro Kishimoto, Hiroyuki Harada, Megumu Hino, Takashi Ishihara	7
4	Hemoglobin A1c predicts heart failure hospitalization independent of baseline cardiac function or B-type natriuretic peptide level 2014 ·Diabetes Research and Clinical Practice ·Ichiro Kishimoto, Hisashi Makino, (unknown), Tamiko Tamanaha, Mayu Tochiya, Akiko Kada, Masaharu Ishihara, Toshihisa Anzai, Wataru Shimizu, Satoshi Yasuda, Hisao Ogawa	18
5	Defining Patients at Extremely High Risk for Coronary Artery Disease in Heterozygous Familial Hypercholesterolemia 2012 ·Journal of Atherosclerosis and Thrombosis ·(unknown), Tomonori Okamura, Hisashi Makino, Makoto Watanabe, Ichiro Kishimoto, Yoshihiro Miyamoto, Noriyuki Iwamoto, Akira Yamamoto, Shinji Yokoyama, Mariko Harada‐Shiba	21
6	Natriuretic Peptide Receptor Guanylyl Cyclase-A Protects Podocytes from Aldosterone-Induced Glomerular Injury 2012 ·Journal of the American Society of Nephrology ·Yoshihisa Ogawa, Masashi Mukoyama, Hideki Yokoi, Masato Kasahara, Kiyoshi Mori, Yukiko Kato, Takashige Kuwabara, Hirotaka Imamaki, (unknown), Kenichi Koga, Akira Ishii, Takeshi Tokudome, Ichiro Kishimoto, Akira Sugawara, Kazuwa Nakao	58
7	Ghrelin and cardiovascular diseases 2011 ·Journal of Cardiology ·Ichiro Kishimoto, Takeshi Tokudome, Hiroshi Hosoda, Mikiya Miyazato, Kenji Kangawa	69
8	Early ghrelin treatment following myocardial infarction prevents an increase in cardiac sympathetic tone and reduces mortality 2010 ·The Journal of Physiological Sciences ·(unknown), Daryl O. Schwenke, Takeshi Tokudome, Ichiro Kishimoto, Kenji Kangawa	1
9	Natriuretic Peptides Enhance the Production of Adiponectin in Human Adipocytes and in Patients With Chronic Heart Failure 2009 ·Journal of the American College of Cardiology ·Osamu Tsukamoto, Masashi Fujita, Mahoto Kato, Satoru Yamazaki, Yoshihiro Asano, Akiko Ogai, Hidetoshi Okazaki, Mitsutoshi Asai, Y. Nagamachi, Norikazu Maeda, Yasunori Shintani, Tetsuo Minamino, Masanori Asakura, Ichiro Kishimoto, Tohru Funahashi, Hitonobu Tomoike, Masafumi Kitakaze	218
10	Pioglitazone treatment stimulates circulating CD34-positive cells in type 2 diabetes patients 2008 ·Diabetes Research and Clinical Practice ·Hisashi Makino, Sadanori Okada, Ayako Nagumo, (unknown), Yoshihiro Miyamoto, Ichiro Kishimoto, (unknown), Toshihiro Soma, Akihiko Taguchi, Yasunao Yoshimasa	20
11	Decreased circulating CD34+ cells are associated with progression of diabetic nephropathy 2008 ·Diabetic Medicine ·Hirofumi Makino, Sadanori Okada, Ayako Nagumo, (unknown), (unknown), Ichiro Kishimoto, Akie Kikuchi‐Taura, Toshihiro Soma, Akihiko Taguchi, Y Yoshimasa	39
12	C‐Type Natriuretic Peptide is a Schwann Cell‐Derived Factor For Development and Function of Sensory Neurones 2008 ·Journal of Neuroendocrinology ·Ichiro Kishimoto, Takeshi Tokudome, T. Horio, Takeshi Soeki, Hideki Chusho, Kazuwa Nakao, Kenji Kangawa	25
13	Ghrelin suppresses cardiac sympathetic activity and prevents early left ventricular remodeling in rats with myocardial infarction 2007 ·American Journal of Physiology-Heart and Circulatory Physiology ·Takeshi Soeki, Ichiro Kishimoto, Daryl O. Schwenke, Takeshi Tokudome, Takeshi Horio, Morikatsu Yoshida, Hiroshi Hosoda, Kenji Kangawa	119
14	C-type natriuretic peptide, a novel antifibrotic and antihypertrophic agent, prevents cardiac remodeling after myocardial infarction 2005 ·Journal of the American College of Cardiology ·Takeshi Soeki, Ichiro Kishimoto, Hiroyuki Okumura, Takeshi Tokudome, Takeshi Horio, Kenji Mori, Kenji Kangawa	154
15	Production and autocrine/paracrine effects of endogenous insulin-like growth factor-1 in rat cardiac fibroblasts 2004 ·Regulatory Peptides ·Takeshi Horio, Toshiyuki Maki, Ichiro Kishimoto, Takeshi Tokudome, Hiroyuki Okumura, Fumiki Yoshihara, Shin‐ichi Suga, Satoshi Takeo, Yuhei Kawano, Kenji Kangawa	30
16	Natriuretic peptides induce NF-κ B activation during myocardial ischemia-reperfusion : possible mechanisms of acute inflammation and coronary endothelial apoptotic cell death 2002 ·Japanese Circulation Journal-english Edition ·(unknown), Ichiro Kishimoto, Masaki Harada, Nobuki Takahashi, Rika Kawakami, Yoshihiko Saito, Kazuwa Nakao	1
17	Blockade of the natriuretic peptide receptor guanylyl cyclase-A inhibits NF-κB activation and alleviates myocardial ischemia/reperfusion injury 2001 ·Journal of Clinical Investigation ·(unknown), Yoshihiko Saito, Ichiro Kishimoto, Masaki Harada, Koichiro Kuwahara, Ichiro Hamanaka, Nobuki Takahashi, Rika Kawakami, Yuhao Li, G. Takemura, Hisayoshi Fujiwara, David L. Garbers, Seibu Mochizuki, Kazuwa Nakao	92
18	Genetic Models Reveal That Brain Natriuretic Peptide Can Signal through Different Tissue-Specific Receptor-Mediated Pathways¹ 2000 ·Endocrinology ·Hideki Chusho, Yoshihiro Ogawa, Naohisa Tamura, Michio Suda, Akihiro Yasoda, Takashi Miyazawa, Ichiro Kishimoto, Yasato Komatsu, (unknown), Kiyoshi Tanaka, Yoshihiko Saito, David L. Garbers, Kazuwa Nakao	32
19	心室筋細胞におけるgp130媒介の生存促進性/抗アポトーシス・シグナリングへのPI3K/Akt/BAD経路の関与 1999 ·Circulation ·(unknown), Yoshimi Saito, Ichiro Kishimoto, Yasuhide Miyamoto, (unknown), Emiko Ogawa, Ichiro Hamanaka, Noboru Kajiyama, Nobuhiro Takahashi, (unknown)	34
20	Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an "emergency" cardiac hormone against ventricular overload. breakdown → 1995 ·Journal of Clinical Investigation ·Osamu Nakagawa, Yoshihiro Ogawa, Hiroaki Itoh, Sachie Suga, Yasato Komatsu, Ichiro Kishimoto, Katsutoshi Nishino, T Yoshimasa, Kazuwa Nakao	536

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact